Search Result "Ros-1 Mutant Lung Cancer"
Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 41 Year: 2019 Page: 7323-7336
Author(s): Elizabeth A. Lopes,Sara Gomes,LucÃlia Saraiva,Maria M.M. Santos
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 5 Year: 2018 Page: 558-574
Author(s): Jens Kohler,Marco Catalano,Chiara Ambrogio
The Role of Systemic Anti-Cancer Therapy in the Management of Lung Carcinoma
Ebook: Frontiers in Lung Cancer
Volume: 1 Year: 2020
Author(s): Alexandra R. Lewis,Laura Cove-Smith
Doi: 10.2174/9789811459566120010014
Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-16
Author(s): Dhi Vya Lim,Wei Hwei Woo,Jing Xuan Lim,Xin Yee Loh,Hui Ting Soh,Seng Yung Adrian Lim,Zheng Yang Lee,Hui Yin Yow,Sharina Binti Hamzah,Jhi Biau Foo
Targeting Apoptotic Signaling Pathways in Human Lung Cancer
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 6 Year: 2010 Page: 566-574
Author(s): S.W. Han, J. Roman
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 8 Year: 2019 Page: 595-630
Author(s): Tatsuya Nagano,Motoko Tachihara,Yoshihiro Nishimura
Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 229-241
Author(s): Lunyin Yu, Hari G. Garg, Boyangzi Li, Robert J. Linhardt, Charles A. Hales
Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 6 Year: 2020 Page: 392-409
Author(s): Sagar O. Rohondia,Zainab Sabry Othman Ahmed,Q. Ping Dou
Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 14 Year: 2018 Page: 1991-2005
Author(s): Habib Zarredar,Khalil Ansarin,Behzad Baradaran,Najibeh Shekari,Shirin Eyvazi,Fateme Safari,Safar Farajnia
Adhesion Molecules in Lung Cancer: Implications in the Pathogenesis and Management
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2173-2183
Author(s): Kostas N. Syrigos, Nikos Katirtzoglou, Elias Kotteas, Kevin Harrington